respiratory

News in brief: Two biomarkers flag accelerated lung function decline in COPD; Decrease in PBS prescriptions for respiratory conditions; COVID-19 vax booster needed for immunocompromised patients: ATAGI

Two biomarkers flag accelerated lung function decline in COPD Two biomarkers can predict people who are likely o develop COPD in middle age, Victorian researchers shave shown. Measuring CC16 and C-reactive protein (CRP) levels in late adulthood could help identify patients with normal or accelerated lung function decline leading to COPD and according to Dr ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic